Transcriptome Sequencing Revealed Significant Alteration of Cortical Promoter Usage and Splicing in Schizophrenia

• Jing Qin Wu,

  Affiliations Schizophrenia Research Institute, Sydney, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health, Priority Research Centre for Translational Neuroscience and Mental Health, The University of Newcastle, New South Wales, Australia, Hunter Medical Research Institute, New Lambton, New South Wales, Australia

  ⨯
• Xi Wang,

  Affiliations School of Biomedical Sciences and Pharmacy, Faculty of Health, Priority Research Centre for Translational Neuroscience and Mental Health, The University of Newcastle, New South Wales, Australia, Hunter Medical Research Institute, New Lambton, New South Wales, Australia

  ⨯
• Natalie J. Beveridge,

  Affiliations Schizophrenia Research Institute, Sydney, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health, Priority Research Centre for Translational Neuroscience and Mental Health, The University of Newcastle, New South Wales, Australia, Hunter Medical Research Institute, New Lambton, New South Wales, Australia

  ⨯
• Paul A. Tooney,

  Affiliations Schizophrenia Research Institute, Sydney, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health, Priority Research Centre for Translational Neuroscience and Mental Health, The University of Newcastle, New South Wales, Australia, Hunter Medical Research Institute, New Lambton, New South Wales, Australia

  ⨯
• Rodney J. Scott,

  Affiliations School of Biomedical Sciences and Pharmacy, Faculty of Health, Priority Research Centre for Translational Neuroscience and Mental Health, The University of Newcastle, New South Wales, Australia, Hunter Medical Research Institute, New Lambton, New South Wales, Australia

  ⨯
• Vaughan J. Carr,

  Affiliations Schizophrenia Research Institute, Sydney, Australia, Research Unit for Schizophrenia Epidemiology, School of Psychiatry, University of New South Wales, St. Vincent's Hospital, Darlinghurst, New South Wales, Australia

  ⨯
• Murray J. Cairns

  * E-mail: murray.cairns@newcastle.edu.au

  Affiliations Schizophrenia Research Institute, Sydney, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health, Priority Research Centre for Translational Neuroscience and Mental Health, The University of Newcastle, New South Wales, Australia, Hunter Medical Research Institute, New Lambton, New South Wales, Australia

  ⨯